JANE STREET GROUP, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$1,327,042
-42.2%
194,012
-23.1%
0.00%
Q1 2024$2,296,439
+292.7%
252,356
+92.5%
0.00%
Q4 2023$584,728
+208.5%
131,105
+117.2%
0.00%
Q3 2023$189,543
-85.7%
60,364
-76.5%
0.00%
Q2 2023$1,327,503
+115.2%
257,268
+119.8%
0.00%
Q1 2023$616,832
+694.7%
117,046
+323.7%
0.00%
Q4 2022$77,620
-17.4%
27,623
+21.9%
0.00%
Q3 2022$94,000
-50.3%
22,658
-51.7%
0.00%
Q2 2022$189,000
-59.4%
46,944
-29.5%
0.00%
Q4 2021$465,000
-68.3%
66,575
-54.6%
0.00%
Q3 2021$1,465,000
-35.2%
146,557
-8.1%
0.00%
Q2 2021$2,260,000
+233.8%
159,395
+286.4%
0.00%
Q1 2021$677,000
-37.9%
41,246
-21.7%
0.00%
Q4 2020$1,090,000
+376.0%
52,653
+74.8%
0.00%
Q3 2020$229,000
-79.3%
30,126
-77.3%
0.00%
-100.0%
Q2 2020$1,107,000
+412.5%
132,900
+205.0%
0.00%
Q1 2020$216,000
+137.4%
43,579
+223.1%
0.00%
Q2 2018$91,00013,4890.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders